Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Staphylococcus Aureus Bacteremia · Staphylococcus Aureus Septicemia · Staphylococcal Sepsis · Staphylococcus Aureus Endocarditis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Foothills Medical Centre, Calgary, Alberta, Canada

    Contact: Principal Investigator (Ranjani Somayaji, MD MPH)
  • Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital), Hamilton, Ontario, Canada

    Contact: Principal Investigator (Dominik Mertz, MD MSc)
  • Niagara Health - St. Catharines site, Saint Catharines, Ontario, Canada

    Contact: Principal Investigator (Aidan Findlater, MD)
  • Hospital de la Cité de la Sante, Laval, Quebec, Canada

    Contact: Study coordinator (Marco Bergevin, MD) · Marco-Andres.Bergevin.med@ssss.gouv.qc.ca
    Contact: Principal Investigator (Marco Bergevin, MD)
  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Principal Investigator (Leighanne Parkes, MD)
  • McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada

    Contact: Study coordinator (Lina Petrella) · lina.petrella@muhc.mcgill.ca · 514-934-1934
    Contact: Principal Investigator (Emily G McDonald, MD MSc)
    Contact: Principal Investigator (Todd C Lee, MD MPH FIDSA)
    Contact: Principal Investigator (Cheng P Matthew, MD)
    Guillaume Butler-Laporte, MD (Sub-investigator)
    Alexander Lawandi, MD MSc (Sub-investigator)
מובילי המחקר
  • Todd C Lee, MD MPH FIDSA

    Principal Investigator

    Research Institute of the McGill University Health Centre

  • Emily G McDonald, MD MSc

    Principal Investigator

    Research Institute of the McGill University Health Centre

  • Matthew P Cheng, MD

    Principal Investigator

    Research Institute of the McGill University Health Centre